Prescribing pattern of antihypertensive drugs in the community

Journal of Human Hypertension

Volumn 10, Issue SUPPL. 3, 1996, Pages

  Rotmensch, Heschi H ^a,b   Mendelevitch, L ^a   Silverberg, D S ^a   Liron, M ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b Maccabi Sick Fund   (Israel)

Author keywords

Antihypertensives; Drug utilization review; Prescribing

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; CLIMATE; COMMUNITY CARE; CONFERENCE PAPER; DRUG USE; FEMALE; HUMAN; HYPERTENSION; ISRAEL; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; POPULATION; PRESCRIPTION; PRIMARY MEDICAL CARE; TREATMENT PLANNING;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; COMMUNITY MEDICINE; CORONARY DISEASE; DIABETES COMPLICATIONS; DIURETICS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED;

EID: 0029761597     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Moser M, Guyther JR, Finnerty F. Joint National Committee Report on Detection, Evaluation and Treatment of High Blood Pressure. JAMA 1977; 237: 255-261.
2. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The 1980 report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1980; 140: 1280-1285.
3. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The 1984 report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Arch Int Med 1984; 144: 1045-1057.
4. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1988; 148: 1023-1038.
5. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The Fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993; 153: 154-183.
6. Materson BJ et al. Single drug therapy for hypertension in men. N Engl J Med 1993; 328: 914-921.
7. Gallup G, Cotugno HE. Preferences and practices of Americans and their physicians in antihypertensive therapy, Am J Med 1986; 81 (Suppl 6C): 20-24.
8. Jerome M, Xakellis GC, Angstman G, Patchin W. Initial medication selection for treatment of hypertension in an open-panel HMO. J Am Board Fam Pract 1995; 8: 1-6.
9. Psaty BM et al. Temporal patterns of antihypertensive medication use among elderly patients: the Cardiovascular Health Study. JAMA 1993; 270: 1837-1841.
10. Monane M et al. Trends in medication choices for hypertension in the elderly. The decline of the thiazides. Hypertension 1995; 25: 1045-1051.
11. Agewall S, Wilkstrand J, Dahlof C, Fagerberg B. A randomized study of quality of life during multiple risk factor intervention in treated hypertensive men at high cardiovascular risk. J Hypertension 1995; 13: 1471-1477.
12. Glynn RJ et al. Use of antihypertensive drugs and trends in blood pressure in the elderly. Arch Intern Med 1995; 155: 1855-1860.
13. Dahlof B et al. Morbidity and mortality in the Swedish trial in old patients with hypertension (Stop-Hypertension). Lancet 1991; 338: 1281-1285.
14. MRC Working Party, Medical Research Council trial of treatment of hypertension in older adults: principle results. Br Med J 1992; 304: 405-412.
15. The Systolic Hypertension in the Elderly Program Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolate systolic hypertension. JAMA 1991; 265: 3255-3264.
16. The Systolic Hypertension in the Elderly Program Coopertive Research Group. Implications of the Systolic Hypertension in the Elderly Program. Hypertension 1993; 21: 335-343.
17. Yusuf S et al. Beta-blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985; 17: 355-371.
18. Rotmensch HH, Vlasses PH, Ferguson RK. Prophylactic use of beta-adrenergic blockage in survivors of myocardial infarction. Heart & Lung 1984; 13: 366-371.
19. Brand DA, Newcomer LN, Freiburger A, Tian H. Cardiologists' practices compared with practice guidelines: use of beta-blockade after acute myocardial infarction. J Am Coll Cardiol 1995; 26: 1432-1436.
20. Viskin S et al. Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice. J Am Coll Cardiol 1995; 25: 1327-1332.
21. Multiple Risk Factor Intervention Trial Research Group. Baseline rest electrocardiographic abnormalities, antihypertensive treatment, and mortality in the Multiple Risk Factor Intervention Trial. Am J Cardiol 1986; 55: 1-15.
22. Herbert PR et al. Recent evidence of drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med 1993; 153: 578-581.
23. Holm I et al. Quality-adjusted meta analysis of the hypertension/coronary dilemma. Am J Hypertens 1994; 7: 703-712.
24. Tobian L et al. Modern strategies to prevent coronary sequelae and stroke in hypertensive patients differ from the JNC V consensus guidelines. Am J Hypertens 1994; 7: 859-872.
25. Gavras H, Gavras I. On the JNC V report. A different point of view. Am J Hypertens 1994; 7: 288-293.
26. Silverberg DS, Rotmensch HH, Iaina A. Low-dose thiazides in the treatment of hypertension: benefits and risks in perspective. J Human Hypertension 1995; 9: 869-873.